1-6 of 6
non-small cell lung cancer stage iv
Close
Sort by
Journal Articles

Phase I Dose Escalation Study of Radiotherapy and Durvalumab (MEDI4736) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The RaDD Study

Eliza A Hawkes, Kate Manos, Geoff Chong, Jodie Palmer, Michael MacManus, Colm Keane, MD, Andrew Scott, Jake Shortt, MBBS FRACP FRCPA PhD, David Ritchie, MD PhD, Leonid Churilov, Laura Johnston, Tom Witkowski, Allison Barraclough, Sze-Ting Lee, Wendi Lin, Rachel Koldej, Richard Khor
Journal: Blood
Blood (2019) 134 (Supplement_1): 5328.
https://doi.org/10.1182/blood-2019-122635
Published: 2019
Journal Articles

Evan's Syndrome Associated with Pembrolizumab Therapy in Metastatic Non-Small Cell Lung Cancer

Anthony Lott, MD, Marcus Butler, MD, Natasha Leighl, MD, Christine M. Cserti-Gazdewich, MD
Journal: Blood
Blood (2015) 126 (23): 4543.
https://doi.org/10.1182/blood.V126.23.4543.4543
Published: 2015
Journal Articles

Risk of Intracranial Hemorrhage Associated with Enoxaparin Administration in Patients with Brain Metastasis

Jessica Donato, MD, Federico Campigotto, MS, Erika Coletti, BSN, Donna Neuberg, ScD, Griffin Weber, MD PhD, Jeffrey I. Zwicker, MD
Journal: Blood
Blood (2014) 124 (21): 348.
https://doi.org/10.1182/blood.V124.21.348.348
Published: 2014
Journal Articles

Clinical and Translational Results from a Phase II Trial of Imprime PGG, Alemtuzumab, and Rituximab in the Early Treatment of Patients with High Risk Chronic Lymphocytic Leukemia

Nandita Bose, PhD, Clive S. Zent, MD, Betsy R. LaPlant, MS, Nadine Ottoson, Steven Leonardo, PhD, George J Weiner, MD, Stephen M. Ansell, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5662.
https://doi.org/10.1182/blood.V124.21.5662.5662
Published: 2014
Journal Articles

The Signature Program, a Distinctive Tissue Agnostic Trial Model for Molecularly Pre-Selected Hematological and Solid Tumor Patients

Frank Giles, MD MB, FRCPI, FRCPath, Sarina A. Piha-Paul, MD, Alexander I. Spira, PhD MD FACP, Fadi Braiteh, MD CPI, Julio Antonio Peguero, MD, Daniel L. Spitz, MD FACP, James A. Knost, MD, Lee Schwartzberg, MD FACP, Steven Stein, MD, August J. Salvado, MD, Claudia Lebedinsky, MD, Barinder Kang, PhD, Eric Slosberg, PhD
Journal: Blood
Blood (2014) 124 (21): 4818.
https://doi.org/10.1182/blood.V124.21.4818.4818
Published: 2014
Journal Articles

Crizotinib in ALK-Positive Diffuse Large B-Cell Lymphoma: A Case Report

Maxi Wass, MD, Timo Behlendorf, MD, Ulrike Gläser, MD, Jörn Rüssel, MD, Fredericke Güntsch, MD, Jordan Karin, MD, Hans-Joachim Schmoll, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4862.
https://doi.org/10.1182/blood.V120.21.4862.4862
Published: 2012